Crinetics Pharmaceuticals (CRNX) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Crinetics Pharmaceuticals (CRNX) over the last 6 years, with Q3 2025 value amounting to -$1.38.
- Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) fell 4375.0% to -$1.38 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.52, marking a year-over-year decrease of 2183.29%. This contributed to the annual value of -$3.68 for FY2024, which is 22.49% up from last year.
- According to the latest figures from Q3 2025, Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) is -$1.38, which was down 4375.0% from -$1.23 recorded in Q2 2025.
- Crinetics Pharmaceuticals' 5-year EPS (Weighted Average and Diluted) high stood at -$0.73 for Q3 2021, and its period low was -$1.38 during Q3 2025.
- Over the past 5 years, Crinetics Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$0.93 (recorded in 2024), while the average stood at -$0.93.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 495.05% in 2024, then tumbled by 4375.0% in 2025.
- Over the past 5 years, Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.8 in 2021, then dropped by 3.55% to -$0.83 in 2022, then fell by 6.02% to -$0.88 in 2023, then decreased by 13.07% to -$0.99 in 2024, then tumbled by 38.7% to -$1.38 in 2025.
- Its last three reported values are -$1.38 in Q3 2025, -$1.23 for Q2 2025, and -$1.04 during Q1 2025.